Medical Developments International (ASX:MVP) EPS (Basic) : A$-0.34 (TTM As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International EPS (Basic)?

Medical Developments International's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was A$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.34.

Medical Developments International's EPS (Diluted) for the six months ended in Dec. 2024 was A$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.34.

Medical Developments International's EPS without NRI for the six months ended in Dec. 2024 was A$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -0.21.

During the past 3 years, the average EPS without NRI Growth Rate was -67.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Medical Developments International's highest 3-Year average EPS without NRI Growth Rate was 71.00% per year. The lowest was -67.40% per year. And the median was -7.20% per year.

Medical Developments International EPS (Basic) Historical Data

The historical data trend for Medical Developments International's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International EPS (Basic) Chart

Medical Developments International Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EPS (Basic)

Get a 7-Day Free Trial

0.01

-0.18

-0.17

-0.07

-0.46

Medical Developments International Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															0.03	-0.10	-0.12	-0.34	-

Medical Developments International EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medical Developments International's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-40.992	-	0)	/	88.602
	=	-0.46

Medical Developments International's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.304	-	0)	/	107.369
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.34

Medical Developments International (ASX:MVP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medical Developments International EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Medical Developments International's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Developments International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

MDDVF:USA

Address

4 Caribbean Drive, Scoresby, VIC, AUS, 3179

Website

https://www.medicaldev.com

Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Medical Developments International Stock Appears To Be Possible Value Trap

By GF Value • 01-01-1970

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire • 03-18-2022